The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
Open accessAbstract
Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second leading cause of cancer death worldwide. While rising incidence of liver cancer in low‐risk areas and decreasing incidence in some high‐risk areas has been reported, trends have not been thoroughly explored by country or by histologic type. We examined liver cancer incidence overall and by histology by calendar time and birth cohort for selected countries between 1978 and 2007. For each successive 5‐year period, age‐standardized incidence rates were calculated from volumes V‐IX of the Cancer Incidence in Five Continents electronic database (CI5 plus) and the newly released CI5X (volume X) database. Wide global variations persist in liver cancer incidence. Rates of liver cancer remain highest in Asian countries, specifically Eastern and South‐Eastern Asian countries. While rates in most of these high‐risk countries have been decreasing in recent years, rates in India and several low‐risk countries of Africa, Europe, the Americas, and Oceania have been on the rise. Liver cancer rates by histologic type tend to convey a similar temporal profile. However, in Thailand, France, and Italy, ICC rates have increased while HCC rates have declined. We expect rates in high‐risk countries to continue to decrease, as the population seroprevalence of hepatitis B virus (HBV) continues to decline. In low‐risk countries, targeted screening and treatment of the hepatitis C virus (HCV), treatment of diabetes and primary prevention of obesity, will be key in reducing future liver cancer incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Models for temporal variation in cancer rates. II: Age–period–cohort models
Clayton, D., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060406 · Cited by 916
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Self-citationImproved survival after variceal bleeding in patients with cirrhosis over the past two decades
Carbonell, N., Pauwels, A., Serfaty, L., Fourdan, O., Lévy, V. G., & Poupon, R. (2004) · Hepatology · doi:10.1002/hep.20339 · Cited by 842
The epidemiology of obesity: the size of the problem
James, W. P. T. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01922.x · Cited by 786
Models for temporal variation in cancer rates. I: Age–period and age–cohort models
Clayton, D., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060405 · Cited by 685
Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue
Dorak, M. T., & Karpuzoglu, E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00268 · Cited by 493
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
Self-citationInternational trends and patterns of primary liver cancer
McGlynn, K. A., Tsao, L., Hsing, A. W., Devesa, S. S., & Fraumeni, J. F. (2001) · International Journal of Cancer · doi:10.1002/ijc.1456 · Cited by 349
Self-citationPopulation-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Welzel, T. M., Graubard, B. I., Quraishi, S., Zeuzem, S., Davila, J. A., El-Serag, H. B., & McGlynn, K. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.160 · Cited by 328
Self-citationCholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology
Okuda, K., Nakanuma, Y., & Miyazaki, M. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02781.x · Cited by 214
Trabert, B., Chen, J., Devesa, S. S., Bray, F., & McGlynn, K. A. (2015) · Andrology · doi:10.1111/andr.293 · Cited by 197
Self-citationCancer risk diversity in non-western migrants to Europe: An overview of the literature
Arnold, M., Razum, O., & Coebergh, J.-W. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.050 · Cited by 196
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Chen, J.-G., Egner, P. A., Ng, D., Jacobson, L. P., Muñoz, A., Zhu, Y.-R., Qian, G.-S., Wu, F., Yuan, J.-M., Groopman, J. D., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0168 · Cited by 164
Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005
Gao, S., Yang, W.-S., Bray, F., Va, P., Zhang, W., Gao, J., & Xiang, Y.-B. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9636-8 · Cited by 159
Self-citationGraphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003
Tanaka, H., Imai, Y., Hiramatsu, N., Ito, Y., Imanaka, K., Oshita, M., Hijioka, T., Katayama, K., Yabuuchi, I., Yoshihara, H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00004 · Cited by 127
Sun, Z., Chen, T., Thorgeirsson, S. S., Zhan, Q., Chen, J., Park, J., Lu, P., Hsia, C. C., Wang, N.-J., Xu, L., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt007 · Cited by 99
Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden
Hemminki, K., & Li, X. (2003) · Gut · doi:10.1136/gut.52.4.592 · Cited by 75
London, W. T., & McGlynn, K. A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0039 · Cited by 71
Self-citationSegi, M., Fujisaku, S., & Kurihara, M. (1957) · PubMed · Cited by 64
International trends in primary liver cancer incidence from 1973 to 2007
Zhang, Y., Ren, J., Shi, J., Li, N., Wang, Y., Qu, C., Zhang, Y., & Dai, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1113-4 · Cited by 60
International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990
Znaor, A., Lortet‐Tieulent, J., Laversanne, M., Jemal, A., & Bray, F. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0486-z · Cited by 46
Self-citationHCV Treatment — No More Room for Interferonologists?
Drenth, J. P. H. (2013) · New England Journal of Medicine · doi:10.1056/nejme1303818 · Cited by 37
Cited by
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Metadata
- Authors
- Petrick, J. L., Braunlin, M., Laversanne, M., Valery, P. C., Bray, F., & McGlynn, K. A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2016-06-28
- Volume
- 139
- Issue
- 7
- Pages
- 1534-1545
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2411616513
- Cited by
- 342
- References
- 31
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.